<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03690934</url>
  </required_header>
  <id_info>
    <org_study_id>74</org_study_id>
    <nct_id>NCT03690934</nct_id>
  </id_info>
  <brief_title>Treatment of Transsphicteric Fistula-in-ano by Method of Laser Thermoobliteration(FiLaC™).</brief_title>
  <official_title>Randomized Conrtolled Study: Fistula Laser Closure (FiLaC™) vs Monopolar Coagulation for Treatment of Complex Anal Fistulae.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>State Scientific Centre of Coloproctology, Russian Federation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>State Scientific Centre of Coloproctology, Russian Federation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized, controlled, parallel study to compare the results of treatment for
      patients with transsphincteric fistulas-in-ano.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We are planning to eroll 120 patients in this study,the duration of the stady be 3 years.
      Each of two groups will include 60 people. Pationts in the first group will be assigned to
      get treatment of the fistula-in-ano by laser thermo-obliteration (FiLAC™), patietns of the
      second group will forego monopolar coagulation of the fistulas tract with suturing the
      internal fistulas opening.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 23, 2017</start_date>
  <completion_date type="Anticipated">August 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Assignment</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of healing</measure>
    <time_frame>60 days</time_frame>
    <description>healing</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Anal Fistula</condition>
  <arm_group>
    <arm_group_label>Fistula-tract laser closure (FiLAC™)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The treatment technique consists of laser coagulation of fistulous tract walls with a diode laser with a wavelength of 1470 nm, which leads to thermo-obliteration of the fistulous tract.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Fistula monopolar cogulation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The treatment technicque consists of monopolar coagulation of fistulous tract walls with suturing the internal fistulas opening.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Fistula-tract laser closure (FiLAC™)</intervention_name>
    <description>The procedure was performed with a diode laser platform emitting laser energy of 15 W at a wavelength of 1470 nm by means of a radial ﬁber. For obliteration, the ﬁstula track is treated with a continuous slow retraction of the laser ﬁbre withdrawn at a rate of approximately 1 cm per 2-3s.</description>
    <arm_group_label>Fistula-tract laser closure (FiLAC™)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Monopolar coagulation of fistulous tract</intervention_name>
    <description>The procedure was performed with a monopolar coagulator platform emitting monopolar coagulation. For obliteration, the ﬁstula track is treated with a continuous slow retraction of the monopolar energy with suturing the internal fistulas opening.</description>
    <arm_group_label>Fistula monopolar cogulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Informed consent to the study;

          2. Patients with high transsphincteric fistula (&gt;1/3), suprasphincteric fistula whithout
             abscesses;

          3. The presence of a formed fistulous tract &gt; 2 cm in length.

        Exclusion Criteria:

          1. Suprasphincteric fistula with abscesses or infiltrates;

          2. Extrasphincteric fistula;

          3. Length of fistula tract &lt; 2 cm;

          4. The presence of sever scars in the region of internal fistula opening, wide fistula
             opening &gt; 5 mm;

          5. Crohn's fistulae
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Ivan Kostarev, MD</last_name>
    <phone>+7-499-199-63-98</phone>
    <email>djovani_80@mail.ru</email>
  </overall_contact>
  <location>
    <facility>
      <name>State Scientific Centre of Coloproctology</name>
      <address>
        <city>Moscow</city>
        <zip>123423</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ivan Kostarev, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Russian Federation</country>
  </location_countries>
  <verification_date>October 2018</verification_date>
  <study_first_submitted>September 12, 2018</study_first_submitted>
  <study_first_submitted_qc>September 28, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 1, 2018</study_first_posted>
  <last_update_submitted>November 13, 2018</last_update_submitted>
  <last_update_submitted_qc>November 13, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">November 14, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rectal Fistula</mesh_term>
    <mesh_term>Fistula</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

